新闻中心

EGFR-MutCell Platform: A Precision Target Model Construction Platform to Overcome Resistance to Third-Generation EGFR Inhibitors

Kyinno Biotechnology 29.01.2026

了解更多 »

From Precise Off-Target Screening to ADCC Effect Evaluation: MPSA-AB5000 Combined With CD3 Gene Knockout Reporter Cells, Multidimensionally Empowering

Kyinno Biotechnology 29.01.2026

了解更多 »

From “Undruggable” to Precision Targeting: A New Leap in KRAS-Targeted Cancer Therapy

Kyinno Biotechnology 29.01.2026

了解更多 »

Dual-Specific ADCs Break Through Solid Tumor Therapy: Successful Practice of Multi-Target Strategies and CDX Model Validation

Kyinno Biotechnology 29.01.2026

了解更多 »

WRN MutCell Platform Accelerates Precision Resistance Research and Drives Breakthroughs in Novel Drug Development

Kyinno Biotechnology 29.01.2026

了解更多 »

$100B Nuclear Medicine Star Target ACP3 Reshapes the Prostate Cancer Treatment Landscape

Kyinno Biotechnology 29.01.2026

了解更多 »

CRBN-KO Can Still Show Drug Activity? This BTK Degrader Is Seriously Impressive

Kyinno Biotechnology 29.01.2026

了解更多 »

The STEAP Protein Family: Transmembrane “Express Channels” and the Next Promising Targets in Cancer Therapy

Kyinno Biotechnology 05.01.2026

了解更多 »

WRN-MutCell Platform: Empowering Precision Drug-Resistance Research · Driving Breakthroughs in Novel Therapeutics

Kyinno Biotechnology 30.12.2025

了解更多 »